Mutated immunoglobulin-binding polypeptides

An Fc-binding polypeptide of improved alkali stability, comprising a mutant of a parental Fc-binding domain of Staphylococcus Protein A (SpA), as defined by SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 22, SEQ ID NO: 51 or SEQ ID NO: 52...

Full description

Saved in:
Bibliographic Details
Main Authors Bjorkman, Tomas, Ander, Mats, Rodrigo, Gustav José
Format Patent
LanguageEnglish
Published 16.07.2024
Subjects
CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOIDCHEMISTRY
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PERFORMING OPERATIONS
PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
SEPARATION
THEIR RELEVANT APPARATUS
TRANSPORTING
Online AccessGet full text

Cover

Abstract An Fc-binding polypeptide of improved alkali stability, comprising a mutant of a parental Fc-binding domain of Staphylococcus Protein A (SpA), as defined by SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 22, SEQ ID NO: 51 or SEQ ID NO: 52, wherein at least the asparagine or serine residue at the position corresponding to position 11 in SEQ ID NO: 4-7 has been mutated to an amino acid selected from the group consisting of glutamic acid, lysine, tyrosine, threonine, phenylalanine, leucine, isoleucine, tryptophan, methionine, valine, alanine, histidine and arginine.
AbstractList An Fc-binding polypeptide of improved alkali stability, comprising a mutant of a parental Fc-binding domain of Staphylococcus Protein A (SpA), as defined by SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 22, SEQ ID NO: 51 or SEQ ID NO: 52, wherein at least the asparagine or serine residue at the position corresponding to position 11 in SEQ ID NO: 4-7 has been mutated to an amino acid selected from the group consisting of glutamic acid, lysine, tyrosine, threonine, phenylalanine, leucine, isoleucine, tryptophan, methionine, valine, alanine, histidine and arginine.
Author Rodrigo, Gustav José
Bjorkman, Tomas
Ander, Mats
Author_xml – fullname: Bjorkman, Tomas
– fullname: Ander, Mats
– fullname: Rodrigo, Gustav José
BookMark eNrjYmDJy89L5WTQ9i0tSSxJTVHIzM0tzctPz8lPKs3JzNNNysxLycxLVyjIz6ksSC0oyUxJLeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfGhwYZGBsbmxqaWTkbGxKgBALE-LC8
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US12037359B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US12037359B23
IEDL.DBID EVB
IngestDate Fri Aug 02 08:57:09 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US12037359B23
Notes Application Number: US202017114773
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240716&DB=EPODOC&CC=US&NR=12037359B2
ParticipantIDs epo_espacenet_US12037359B2
PublicationCentury 2000
PublicationDate 20240716
PublicationDateYYYYMMDD 2024-07-16
PublicationDate_xml – month: 07
  year: 2024
  text: 20240716
  day: 16
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies CYTIVA BIOPROCESS R&D AB
RelatedCompanies_xml – name: CYTIVA BIOPROCESS R&D AB
Score 3.5470264
Snippet An Fc-binding polypeptide of improved alkali stability, comprising a mutant of a parental Fc-binding domain of Staphylococcus Protein A (SpA), as defined by...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOIDCHEMISTRY
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PERFORMING OPERATIONS
PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
SEPARATION
THEIR RELEVANT APPARATUS
TRANSPORTING
Title Mutated immunoglobulin-binding polypeptides
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240716&DB=EPODOC&locale=&CC=US&NR=12037359B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp6LzgwrSFym2Sz_MQxH6xRC6DbfK3kbaZDCRtdgO_30voXO-6FtI4JIc3MfvcncBuEcfvzCZYxqc8CcEKIQYbLDkBiksKig6EDmRxcnpyB1m9svcmXfgfVsLo_qEfqnmiChRBcp7o_R1tQtiRSq3sn7MVzhVPiczP9JbdKzgiatHgR9PxtE41MPQz6b66NW3BibxiEMDVNd76EZ7Mv0rfgtkVUr126Qkx7A_QWrr5gQ6Yt2Dw3D781oPDtL2wRuHrezVp_CQbqRjyLWVLOkoZScPmUUuoa20P1pVfiCmRA3ARX0Gd0k8C4cG7rr4ueIim-4OSM6hi9BfXICGjEIbS8WAEWYj9KAFt3NGqc0KD6GNdQn9v-n0_1u8giPJLhmltNxr6DafG3GD5rXJbxVfvgHrLH7w
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq6L1FUFykWCSTdLuIQh5EbVJi02kt5LHChVpgknx7zsbUutFb8suzO4OzOObnZkFuEUfP5MTXZZyko8QoBAiJepbLpFMoYyiA5ESXpwchIYfa09zfd6B900tTNMn9KtpjogSlaG8142-LrdBLKfJrazu0yVOFQ9eZDpii44beGKIjmW604kzsUXbNuOZGL6YiiqTIdGphep6B13sEe-z775avCql_G1SvAPYnSK1VX0IHbbqQ8_e_LzWh72gffDGYSt71RHcBWvuGObCkpd0FLyTB88i59CW2x-hLD4QU6IGyFl1DDeeG9m-hLsufq64iGfbA5IT6CL0Z6cgIKPQxlKmJiTREHrQLNfShFItyYYIbZQzGPxNZ_Df4jX0_CgYL8aP4fM57HPW8YilYlxAt_5cs0s0tXV61fDoGwZzgeA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Mutated+immunoglobulin-binding+polypeptides&rft.inventor=Bjorkman%2C+Tomas&rft.inventor=Ander%2C+Mats&rft.inventor=Rodrigo%2C+Gustav+Jos%C3%A9&rft.date=2024-07-16&rft.externalDBID=B2&rft.externalDocID=US12037359B2